(Q43102333)

English

Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib.

scientific article published on 12 April 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6366340&resulttype=core&format=json

13 May 2020

chronic myeloid leukemia

0 references

0 references

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6366340&resulttype=core&format=json

13 May 2020

Mathieu Molimard

14

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6366340&resulttype=core&format=json

13 May 2020

author name string

David Marin

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6366340&resulttype=core&format=json

13 May 2020

Alexandra Bazeos

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6366340&resulttype=core&format=json

13 May 2020

Francois-Xavier Mahon

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6366340&resulttype=core&format=json

13 May 2020

Lina Eliasson

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6366340&resulttype=core&format=json

13 May 2020

Dragana Milojkovic

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6366340&resulttype=core&format=json

13 May 2020

Marco Bua

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6366340&resulttype=core&format=json

13 May 2020

Jane F Apperley

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6366340&resulttype=core&format=json

13 May 2020

Ritti Desai

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6366340&resulttype=core&format=json

13 May 2020

Kasia Kozlowski

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6366340&resulttype=core&format=json

13 May 2020

Christos Paliompeis

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6366340&resulttype=core&format=json

13 May 2020

Victoria Latham

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6366340&resulttype=core&format=json

13 May 2020

Letizia Foroni

13

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6366340&resulttype=core&format=json

13 May 2020

Alistair Reid

15

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6366340&resulttype=core&format=json

13 May 2020

Katy Rezvani

16

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6366340&resulttype=core&format=json

13 May 2020

Hugues de Lavallade

17

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6366340&resulttype=core&format=json

13 May 2020

Cristina Guallar

18

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6366340&resulttype=core&format=json

13 May 2020

John Goldman

19

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6366340&resulttype=core&format=json

13 May 2020

Jamshid S Khorashad

20

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6366340&resulttype=core&format=json

13 May 2020

language of work or name

0 references

publication date

12 April 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6366340&resulttype=core&format=json

13 May 2020

28

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6366340&resulttype=core&format=json

13 May 2020

14

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6366340&resulttype=core&format=json

13 May 2020

2381-2388

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6366340&resulttype=core&format=json

13 May 2020

Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adherence to therapy with oral antineoplastic agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical heterogeneity in chronic myeloid leukaemia reflecting biological diversity in normal persons

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic Myeloid Leukemia — Advances in Biology and New Approaches to Treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Active transport of imatinib into and out of cells: implications for drug resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring patients in complete cytogenetic remission after treatment of CML in chronic phase with imatinib: patterns of residual leukaemia and prognostic factors for cytogenetic relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adherence to Medication

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplantation for chronic myeloid leukemia: an attempt to define patients who may not require further therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The presence of a BCR-ABL mutant allele in CML does not always explain clinical resistance to imatinib

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

OCT-1-mediated influx is a key determinant of the intracellular uptake of imatinib but not nilotinib (AMN107): reduced OCT-1 activity is the cause of low in vitro sensitivity to imatinib

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient-centred advice is effective in improving adherence to medicines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

International standardisation of quantitative real-time RT-PCR for BCR-ABL

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment interruptions and non-adherence with imatinib and associated healthcare costs: a retrospective analysis among managed care patients with chronic myelogenous leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of the uptake drug transporter hOCT1 is an important clinical determinant of the response to imatinib in chronic myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Most CML patients who have a suboptimal response to imatinib have low OCT-1 activity: higher doses of imatinib may overcome the negative impact of low OCT-1 activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interventions for enhancing medication adherence

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib for newly diagnosed patients with chronic myeloid leukemia: incidence of sustained responses in an intention-to-treat analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Finding of kinase domain mutations in patients with chronic phase chronic myeloid leukemia responding to imatinib may identify those at high risk of disease progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient adherence and persistence with oral anticancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Compliance declines between clinic visits

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic discrimination in "good-risk" chronic granulocytic leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between the proportion of Philadelphia chromosome-positive metaphase cells and levels ofBCR-ABL mRNA in chronic myeloid leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring

1 reference

https://pubmed.ncbi.nlm.nih.gov/20385986

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2009.26.3087

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6366340&resulttype=core&format=json

13 May 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6366340&resulttype=core&format=json

13 May 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6366340&resulttype=core&format=json

13 May 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43102333&oldid=1595201151"